Hmn_老虎社区_美港股上老虎

2021-11-09

Hmn

Moderna seeks EU authorization for COVID-19 vaccine in young kids<blockquote>Moderna 寻求欧盟授权幼儿 COVID-19 疫苗</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":847022579,"tweetId":"847022579","gmtCreate":1636469148186,"gmtModify":1636469148455,"author":{"id":3562110654160486,"idStr":"3562110654160486","authorId":3562110654160486,"authorIdStr":"3562110654160486","name":"Angelinetang","avatar":"https://static.tigerbbs.com/db70c1a81c4a4398c4b43ef2d5c8c35d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Hmn</p></body></html>","htmlText":"<html><head></head><body><p>Hmn</p></body></html>","text":"Hmn","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/847022579","repostId":1111023702,"repostType":4,"repost":{"id":"1111023702","kind":"news","pubTimestamp":1636466834,"share":"https://www.laohu8.com/m/news/1111023702?lang=zh_CN&edition=full","pubTime":"2021-11-09 22:07","market":"us","language":"en","title":"Moderna seeks EU authorization for COVID-19 vaccine in young kids<blockquote>Moderna 寻求欧盟授权幼儿 COVID-19 疫苗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1111023702","media":"Reuters","summary":"Nov 9 (Reuters) - Moderna Inc on Tuesday sought conditional marketing authorization with the Europea","content":"<p>Nov 9 (Reuters) - Moderna Inc on Tuesday sought conditional marketing authorization with the European Medicines Agency for use of its COVID-19 vaccine in children in the age-group of 6-11 years.</p><p><blockquote>路透11月9日 - Moderna Inc.周二向欧洲药品管理局寻求有条件营销授权，在6-11岁年龄组的儿童中使用其新冠肺炎疫苗。</blockquote></p><p> The vaccine was authorized for use in teens aged 12 to 17 years by the European Union in July, but several countries including Sweden have paused its use for people aged 30 and younger due to rare heart-related side-effects.</p><p><blockquote>该疫苗于 7 月获得欧盟授权用于 12 至 17 岁青少年，但由于罕见的心脏相关副作用，包括瑞典在内的几个国家已暂停用于 30 岁及以下人群。</blockquote></p><p> The drugmaker sought U.S. authorization of its vaccine for use in teens in June and is awaiting a decision by the U.S. Food and Drug Administration.</p><p><blockquote>该制药商于 6 月份寻求美国授权其疫苗用于青少年，并正在等待美国的决定。食品药品监督管理局。</blockquote></p><p> \"This marks our first submission for the use of our vaccine in this age group,\" said Stéphane Bancel, Chief Executive of Moderna, adding the company will submit the data to other regulatory agencies around the world.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 表示：“这标志着我们首次提交在该年龄段使用疫苗的申请。”他补充说，该公司将向世界各地的其他监管机构提交数据。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna seeks EU authorization for COVID-19 vaccine in young kids<blockquote>Moderna 寻求欧盟授权幼儿 COVID-19 疫苗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna seeks EU authorization for COVID-19 vaccine in young kids<blockquote>Moderna 寻求欧盟授权幼儿 COVID-19 疫苗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-09 22:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Nov 9 (Reuters) - Moderna Inc on Tuesday sought conditional marketing authorization with the European Medicines Agency for use of its COVID-19 vaccine in children in the age-group of 6-11 years.</p><p><blockquote>路透11月9日 - Moderna Inc.周二向欧洲药品管理局寻求有条件营销授权，在6-11岁年龄组的儿童中使用其新冠肺炎疫苗。</blockquote></p><p> The vaccine was authorized for use in teens aged 12 to 17 years by the European Union in July, but several countries including Sweden have paused its use for people aged 30 and younger due to rare heart-related side-effects.</p><p><blockquote>该疫苗于 7 月获得欧盟授权用于 12 至 17 岁青少年，但由于罕见的心脏相关副作用，包括瑞典在内的几个国家已暂停用于 30 岁及以下人群。</blockquote></p><p> The drugmaker sought U.S. authorization of its vaccine for use in teens in June and is awaiting a decision by the U.S. Food and Drug Administration.</p><p><blockquote>该制药商于 6 月份寻求美国授权其疫苗用于青少年，并正在等待美国的决定。食品药品监督管理局。</blockquote></p><p> \"This marks our first submission for the use of our vaccine in this age group,\" said Stéphane Bancel, Chief Executive of Moderna, adding the company will submit the data to other regulatory agencies around the world.</p><p><blockquote>Moderna 首席执行官 Stéphane Bancel 表示：“这标志着我们首次提交在该年龄段使用疫苗的申请。”他补充说，该公司将向世界各地的其他监管机构提交数据。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/1-moderna-seeks-eu-authorization-140344081.html\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/1-moderna-seeks-eu-authorization-140344081.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111023702","content_text":"Nov 9 (Reuters) - Moderna Inc on Tuesday sought conditional marketing authorization with the European Medicines Agency for use of its COVID-19 vaccine in children in the age-group of 6-11 years.\nThe vaccine was authorized for use in teens aged 12 to 17 years by the European Union in July, but several countries including Sweden have paused its use for people aged 30 and younger due to rare heart-related side-effects.\nThe drugmaker sought U.S. authorization of its vaccine for use in teens in June and is awaiting a decision by the U.S. Food and Drug Administration.\n\"This marks our first submission for the use of our vaccine in this age group,\" said Stéphane Bancel, Chief Executive of Moderna, adding the company will submit the data to other regulatory agencies around the world.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1396,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/847022579"}